Home | My Account | Online Store | Contact & Demand | Press Room | About Us | FAQs
Home
Buy & Subscribe
Special Features
Products & Services
Online Store
Products by category
Products by publisher
Product lines
News Channels
Biotechnology
Therapeutic Areas
Business
RSS Feeds
Free RSS News
Get the latest news direct
to your desktop
feed image

Search in our News Channels

Cheap OEM Software
  

Search in our Online Store
Other Disease Areas
Filter     Order     Display # 
Date Item Title
07 Apr 2008 Urigen Announces Early Closure of URG101 Phase II Clinical Trial based on Positive Interim Analysis Results
07 Apr 2008 Callisto Pharmaceuticals Files IND for SP-304 (Guanilib) in Chronic Constipation and Irritable Bowel Syndrome
02 Apr 2008 The FDA accepts the complete response for clinical holds of FG-2216/FG-4592 for the Treatment of Anemia
01 Apr 2008 ThromboGenics Completes Patient Enrolment in the Phase IIb Trial of
01 Apr 2008 VIVUS Completes Special Protocol Assessment for Phase 3 Efficacy Studies and Reaches Agreement with the FDA on the Safety Study for Luramist (Testosterone MDTS)
01 Apr 2008 ISTA Pharmaceuticals Announces Results of Clinical Trial of Xibrom(TM) QD (Once-Daily) Formulation
31 Mar 2008 DUSA Completes Enrollment for Phase IIb Trial of Levulan(R) Photodynamic Therapy for Moderate to Severe Acne
28 Mar 2008 Positive Results From Visudyne (R) Combination Therapy Study Reported at Annual Macula Society Conference
27 Mar 2008 Keryx Biopharmaceuticals Announces Termination of SUN-MACRO Phase 4 Trial
27 Mar 2008 Vertex Announces Positive Results for VX-770, an Oral Investigational Agent That Targets a Defective Protein Responsible for Cystic Fibrosis
26 Mar 2008 Æterna Zentaris Begins Second Phase 3 Trial of Cetrorelix for Benign Prostatic Hyperplasia
18 Mar 2008 TorreyPines Therapeutics Initiates Phase II Study of Muscarinic Agonist NGX267 for Treatment of Xerostomia
17 Mar 2008 Ipsen and Medicis Announce Submission of Reloxin BLA in Aesthetics to the FDA
14 Mar 2008 Isolagen, Inc. Completes Enrollment in Isolagen Therapy(TM) Phase II/III Acne Scar Study
12 Mar 2008 Wyeth and Progenics Provide Update on Phase 3 Clinical Trial of Intravenous Methylnaltrexone for Postoperative Ileus
12 Mar 2008 Urigen Announces Positive Phase II Clinical Trial Results with URG101
11 Mar 2008 OXiGENE Reports Positive Primate Ocular Tolerance and Penetration Data with Topical Formulation of ZYBRESTAT(TM) for Ophthalmology
11 Mar 2008 FDA Advisory Committee Unanimously Recommends U.S. Approval of Sugammadex, the First and Only Selective Relaxant Binding Agent
11 Mar 2008 Schering-Plough Announces Filing of U.S. Application for OTC ZEGERID(R)
11 Mar 2008 Schering-Plough Announces Filing of U.S. Application for OTC ZEGERID(R)
10 Mar 2008 Conclusion of Co-Development and Co-Marketing Agreement on Z-338 for Functional Dyspepsia in Japan with Astellas Pharma Inc.
10 Mar 2008 Halozyme Therapeutics Presents Favorable New Safety and Pharmacokinetic Data on rHuPH20 Enzyme Produced Via New Manufacturing Process at European Federation for Pharmaceutical Sciences
10 Mar 2008 ZARS Pharma Announces Worldwide License Agreement with Galderma Pharma
10 Mar 2008 Anesiva Announces Submission of Supplemental New Drug Application for Zingo(TM) to Reduce Pain Associated With Needle Insertion Procedures in Adults
07 Mar 2008 AlphaMed Pharmaceuticals Announces Breakthrough in the Development of Recombinant Alpha 1-Antitrypsin
07 Mar 2008 Keryx Biopharmaceuticals Announces that the SUN-MICRO Phase 3 Clinical Trial Failed to Meet its Primary Efficacy Endpoint
06 Mar 2008 Alcon Presents Clinical Trial Data on Anecortave Acetate for Glaucoma
06 Mar 2008 Manhattan Pharmaceuticals Successfully Completes Pre-IND Meetings for Altoderm and Altolyn
04 Mar 2008 Microbia and Forest Laboratories Announce Preliminary Results of Linaclotide Phase 2b Studies
03 Mar 2008 Fda approves Aloxi(R) (palonosetron hcl) injection for prevention of postoperative nausea and vomiting
29 Feb 2008 FDA Grants Priority Review for ACIPHEX® sNDA for Short-Term Treatment of GERD in Adolescents
28 Feb 2008 Arriva Pharmaceuticals Moves Forward to Phase 2b Development of Lead Inhaled Protein rAAT Replacement Therapy for Hereditary Emphysema
27 Feb 2008 Sucampo Pharmaceuticals Announces the Initiation of Filings of Marketing Authorization Applications for AMITIZA(R) in Europe
26 Feb 2008 Marillion Pharmaceuticals and Cytokine PharmaSciences Announce License Agreement for Xerostomia Treatment
25 Feb 2008 MacuSight Announces Positive Preliminary Results From Phase 1 Study of Sirolimus in Wet Age-Related Macular Degeneration
25 Feb 2008 Duramed's Lo SEASONIQUE(R) NDA Accepted for Filing by FDA
25 Feb 2008 ESBATech's Antibody Fragments Demonstrate Penetration into the Eye with Tropical Delivery Via Eye Drops
22 Feb 2008 Comparison of AMD Treatments Trials (CATT): Lucentis — Avastin Trial
22 Feb 2008 Moberg Derma Patient Recruitment Finalized to Moberg Derma’s Clinical Phase III Trial for its K101 Product Candidate to Treat Nail Fungus
22 Feb 2008 Moberg Derma Starts Recruiting Patients for Clinical Phase III Trial for its K301 Product Candidate to Treat Seborrheic Dermatitis
20 Feb 2008 Sirion Therapeutics Acquires Worldwide License to Develop New Treatment for Ocular Diseases
19 Feb 2008 AMAG Pharmaceuticals, Inc. Announces FDA Acceptance for Filing of Ferumoxytol New Drug Application in Chronic Kidney Disease
19 Feb 2008 Phosphagenics Initiates US Clinical Trials For Its Topical Retinoic Acid
13 Feb 2008 Inspire Initiates Second Phase 3 Cystic Fibrosis Trial
12 Feb 2008 Ophthotech Enrolls Its First Patient in a Phase I Anti-PDGF Macular Degeneration Trial
12 Feb 2008 Watson Announces Silodosin NDA Accepted for Filing by FDA for the Treatment of Benign Prostatic Hyperplasia
12 Feb 2008 Biovitrum has Completed an Exploratory Clinical Phase II Study in Glaucoma
12 Feb 2008 Depomed Reports Positive Efficacy Data From a Phase 2 Trial of Gabapentin GR(TM) in the Treatment of Menopausal Hot Flashes
11 Feb 2008 Keryx Biopharmaceuticals Completes SUN-MICRO Phase 3 Pivotal Trial
06 Feb 2008 Meditrina Pharmaceuticals, Inc. Announces exclusive global license agreement with AstraZeneca
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
Results 251 - 300 of 985

PipelineReview.com is powered by La Merie Business Intelligence La Merie Business Intelligence

For immediate assistance, please call us during business hours: Mon-Fri 09:00am - 18:30pm; GMT+01

La Merie S.L | Passatge Jordi Ferran, 20 | E-08028 Barcelona | T +34 93 342 91 97 | F +34 93 342 91 98 | Email info@lamerie.com | Internet www.lamerie.com
All contents © by La Merie S. L

Competitor Analysis Series

Diabetes Drug Pipeline

Order Now

Brief Report Series

CD40 and CD40L (CD154) Agonists & Antagonists

Order Now

Subscribe La Merie Biologics